The Amplatzer Septal Occluder, a transcatheter device for atrial septal defect closure.
Transcatheter device closure of secundum atrial septal defect (ASD) has been widely accepted and is becoming the standard treatment of this malformation. Among the devices used for transcatheter closure, the Amplatzer Septal Occluder is the first device to receive full approval from the US FDA for clinical use in patients with secundum ASD. It is safe, user-friendly and effective in closing a wide range of sizes of secundum ASD and has arguably become the most popular device in the world.
Fu
Yun-Ching
YC
Department of Pediatrics, Taichung Veterans General Hospital 160, Taichung, Taiwan, ROC. ivanfu@vghtc.gov.tw
Hijazi
Ziyad M
ZM
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000792:Angiography; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000295:instrumentation*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006344:Heart Septal Defects, Atrial / Q000000981:diagnostic imaging / Q000628:therapy*; D006801:Humans; D007223:Infant; D008875:Middle Aged; D019919:Prosthesis Implantation; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography